+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

From
From
From
From
From
From
Hereditary Angioedema - Pipeline Insight, 2020 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
From
Market Spotlight: Zika virus - Product Thumbnail Image

Market Spotlight: Zika virus

  • Report
  • February 2020
  • 26 Pages
Hereditary Angioedema (HAE) - Pipeline Review, H1 2017 - Product Thumbnail Image

Hereditary Angioedema (HAE) - Pipeline Review, H1 2017

  • Drug Pipelines
  • June 2017
  • 90 Pages
From
Loading Indicator
adroll